Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Regulating dynamic signaling between hematopoietic stem cells and niche cells via a hydrogel matrix.

Mahadik BP, Bharadwaj NA, Ewoldt RH, Harley BA.

Biomaterials. 2017 May;125:54-64. doi: 10.1016/j.biomaterials.2017.02.013. Epub 2017 Feb 14.

PMID:
28231508
2.

VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells.

Jang K, Kim M, Gilbert CA, Simpkins F, Ince TA, Slingerland JM.

EMBO Mol Med. 2017 Mar;9(3):304-318. doi: 10.15252/emmm.201606840.

3.

Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Hu K, Olsen BR.

Dev Dyn. 2017 Apr;246(4):227-234. doi: 10.1002/dvdy.24463. Epub 2016 Dec 29. Review.

PMID:
27750398
4.

Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Doster DL, Jensen AR, Khaneki S, Markel TA.

Cytotherapy. 2016 Dec;18(12):1457-1470. doi: 10.1016/j.jcyt.2016.08.001. Epub 2016 Oct 10. Review.

PMID:
27745788
5.

Roxarsone induces angiogenesis via PI3K/Akt signaling.

Wang Y, Yin D, Xu C, Wang K, Zheng L, Zhang Y.

Cell Biosci. 2016 Sep 28;6:54. eCollection 2016.

6.

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.

Kirschbaum MH, Frankel P, Synold TW, Zain J, Claxton D, Tuscano J, Newman EM, Gandara DR, Lara PN Jr.

Br J Haematol. 2016 Sep 21. doi: 10.1111/bjh.14333. [Epub ahead of print] No abstract available.

PMID:
27650362
7.

Fell-Muir Lecture: Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders.

Olsen BR, Berendsen AD, Besschetnova TY, Duan X, Hu K.

Int J Exp Pathol. 2016 Aug;97(4):296-302. doi: 10.1111/iep.12198. Epub 2016 Sep 1. Review.

PMID:
27581728
8.

Distinguishing autocrine and paracrine signals in hematopoietic stem cell culture using a biofunctional microcavity platform.

Müller E, Wang W, Qiao W, Bornhäuser M, Zandstra PW, Werner C, Pompe T.

Sci Rep. 2016 Aug 18;6:31951. doi: 10.1038/srep31951.

9.

Multiple genetically engineered humanized microenvironments in a single mouse.

Lee J, Heckl D, Parekkadan B.

Biomater Res. 2016 Jun 28;20:19. doi: 10.1186/s40824-016-0066-2. eCollection 2016.

10.

The roles of vascular endothelial growth factor in bone repair and regeneration.

Hu K, Olsen BR.

Bone. 2016 Oct;91:30-8. doi: 10.1016/j.bone.2016.06.013. Epub 2016 Jun 25. Review.

PMID:
27353702
11.

Angiopoietin-1 facilitates recovery of hematopoiesis in radiated mice.

Sun L, Zhang H, Bi L, Shi YF, Xing C, Tang L, Jiang S, Yu K.

Am J Transl Res. 2016 May 15;8(5):2011-21. eCollection 2016.

12.

Vascular endothelial growth factor from embryonic status to cardiovascular pathology.

Azimi-Nezhad M.

Rep Biochem Mol Biol. 2014 Apr;2(2):59-69. Review.

13.

Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Osterberg N, Ferrara N, Vacher J, Gaedicke S, Niedermann G, Weyerbrock A, Doostkam S, Schaefer HE, Plate KH, Machein MR.

Neuro Oncol. 2016 Jul;18(7):939-49. doi: 10.1093/neuonc/now005. Epub 2016 Mar 6.

14.

Targeting the tumour microenvironment in ovarian cancer.

Hansen JM, Coleman RL, Sood AK.

Eur J Cancer. 2016 Mar;56:131-43. doi: 10.1016/j.ejca.2015.12.016. Epub 2016 Feb 3. Review.

15.

Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair.

Hu K, Olsen BR.

J Clin Invest. 2016 Feb;126(2):509-26. doi: 10.1172/JCI82585. Epub 2016 Jan 5.

16.

The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer.

Zhu X, Zhou W.

Front Endocrinol (Lausanne). 2015 Oct 9;6:159. doi: 10.3389/fendo.2015.00159. eCollection 2015. Review.

17.

Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science.

Choi JS, Mahadik BP, Harley BA.

Biotechnol J. 2015 Oct;10(10):1529-45. doi: 10.1002/biot.201400758. Epub 2015 Sep 10. Review.

18.

Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia.

Charnock-Jones DS.

J Reprod Immunol. 2016 Apr;114:81-5. doi: 10.1016/j.jri.2015.07.004. Epub 2015 Jul 18.

19.

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors.

Schmidinger M.

EJC Suppl. 2013 Sep;11(2):172-91. doi: 10.1016/j.ejcsup.2013.07.016. Review. No abstract available.

20.

PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Park S, Sorenson CM, Sheibani N.

Clin Sci (Lond). 2015 Aug;129(3):217-34. doi: 10.1042/CS20140714. Review.

Supplemental Content

Support Center